Valeant Pharma (VRX) option implied volatility elevated into Q1 and outlook

Valeant Pharma (NYSE: VRX) May weekly call option implied volatility is at 117, May is at 80, June is at 55; compared to its 52-week range of 41 to 87 into the expected release of Q1 results before the open on May 8.

You May Also Be Interested In

• Meta Platforms (META) call put ratio 1.7 calls to 1 put with a focus on 11200 contracts of October 16 calls trading at $60
• Interactive Brokers (IBKR) call put ratio 1 call 2.5 puts with a focus on October 84, 85 and 90 puts
• Charles Schwab (SCHW) call put ratio 1 call 2 puts with a focus on September 90 puts